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BACKGROUND. Although narrative reviews have concluded that there is strong
support for an association between cigarette smoking and urinary tract cancer, the
association has never been quantified systematically in reviews. The purpose of
this systematic review was to summarize and quantify the impact of different
smoking characteristics (status, amount, duration, cessation, and age at first ex-
posure) both unadjusted and adjusted for age and gender.
METHODS. The authors included 43 epidemiologic studies (8 cohort and 35 case–
control) and calculated summary odds ratios (SORs) by meta-regression analyses
for different smoking characteristics. They also evaluated changes in summary
estimates according to differences in study methodology.
RESULTS. Smoking status and increased amount and duration of smoking were
associated with a strong increased risk of urinary tract cancer. Smoking cessation
and age at first exposure were negatively associated with the risk of urinary tract
cancer. The age- and gender-adjusted SORs for current and former cigarette
smokers compared with those for nonsmokers were 3.33 (95% confidence interval
[CI], 2.63– 4.21) and 1.98 (CI, 1.72–2.29), respectively. Even though the component
studies differed in methodology, the results were rather consistent.
CONCLUSIONS. The results suggest a substantial increase in risk of cancer of the
urinary tract for cigarette smokers. Based on the results of this study and previous
literature, the authors conclude that current cigarette smokers have an approxi-
mately threefold higher risk of urinary tract cancer than nonsmokers. In Europe,
approximately half of urinary tract cancer cases among males and one-third of
cases among females might be attributable to cigarette smoking. Cancer 2000;89:
630 –9. © 2000 American Cancer Society.
KEYWORDS: cigarette smoking, urologic neoplasms, bladder neoplasms, meta-
analysis, epidemiology.
Over the last 4 decades, many epidemiologic studies have beenconducted to investigate an association between cigarette smok-
ing and the development of urinary tract cancer. Currently, a sub-
stantial amount of evidence has accumulated in support of a positive
association between cigarette smoking and urinary tract cancer risk. A
positive association has been consistently shown in both men and
women in many different geographic areas. Similar results have been
obtained in numerous case– control and follow-up studies.
Although cigarette smoking explains the occurrence of a greater
amount of urinary tract cancer than does any other known environ-
mental factor (e.g., occupation)1 and no other environmental factor
has been shown to confound this association, to our knowledge no
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systematic review on the association between several
smoking characteristics and urinary tract cancer has
been conducted.
Earlier narrative reviews on cigarette smoking and
urinary tract cancer have summarized the association
for current cigarette smoking compared with non-
smokers by estimating a general relative risk without
calculation or systematic collection of data.1–9 Accord-
ing to these narrative reviews, typical cigarette smok-
ers have two to four times the risk of nonsmokers.
Most narrative reviews suggested that the risk of uri-
nary tract cancer increases with the number of ciga-
rettes regularly smoked.1,3–11
The magnitude of the effects of other cigarette
smoking characteristics (e.g., smoking duration and
cessation or age at first exposure) also has not been
systematically reviewed. Although duration of smok-
ing has been evaluated less often than intensity, some
narrative reviews reported an unquantified positive
dose–response relation.3,5,6 According to some re-
views, former cigarette smokers seem to have a re-
duced incidence of urinary tract cancer as compared
with current smokers.4 – 8,11 Age at first exposure to
smoking has been reported only occasionally in nar-
rative reviews of cigarette smoking and urinary tract
cancer.
The purpose of the current study was to review all
epidemiologic studies from 1966 to March 2000 more
systematically; to provide quantitative summary esti-
mates of the risk of urinary tract cancer with emphasis
on smoking status, duration, amount, cessation, and
age at first exposure based on these studies; and to
evaluate changes in summary estimates according to
differences in study methodology.
METHODS
Search Strategy
The study design has been published previously.12
Epidemiologic studies were identified through com-
puterized MEDLINE, CANCERLIT, and Current Con-
tents searches for follow-up and case– control studies
published until March 2000. The keywords used were
urolo*, bladder, cyst*, vesic*, kidney, glomerul*,
nephr*, pyel*, renal, ureteral, urethral, transitional
cell, cancer, carcino*, tumo*, neoplasm*, onco*, risk,
etiology, epidemiology, and caus*. References cited in
published original and review articles were examined
further. For inclusion in this analysis, the articles had
to provide sufficient information to estimate a sum-
mary odds ratio and the associated standard error of
incident primary urinary tract cancer for at least one
of the following cigarette smoking characteristics: cig-
arette smoking status, average daily cigarette con-
sumption, total duration of cigarette consumption,
number of years since cessation, and age at first ex-
posure of smoking. Urinary tract cancer was defined
as cancer of the renal pelvis, ureter, urinary bladder, or
urethra.
Data Collection
We developed a criteria list for the assessment of qual-
ity items (study characteristics) in observational can-
cer research. This list is used to provide covariables for
inclusion in meta-regression models to explore rea-
sons for observed heterogeneity in results between
observational studies. The criteria list has been vali-
dated on published articles on alcohol intake associ-
ated with bladder cancer through consensus meetings
with experts on the fields of cancer and meta-analysis.
The list calls for the following: general information—
year of publication, research design (case– control
study, follow-up study, other, unknown), and geo-
graphic area (Europe, United States, Asia, Africa, un-
known); exposure information— exposure measure-
ment (personal interview, telephone interview,
questionnaire, medical records, other, unknown),
trained interviewer (yes, no, not applicable [n/a], un-
known), validation exposure measurement (yes, no,
unknown), and reference period (number of years,
lifetime, unknown); case information—source cases
(hospital, population, other, unknown), site carci-
noma (renal pelvis, ureter, urinary bladder, urethra,
urinary tract, unknown), histologic confirmation cases
(yes, no, unknown), and percentage transitional cell
tumors; case– control study information—source con-
trols (hospital, population, neighborhood, other, n/a,
unknown), response rate (percentage, n/a, unknown),
and blinding of case status (yes, no, n/a, unknown);
follow-up study information—source study popula-
tion (volunteer, population, other, n/a, unknown),
years of follow-up (number of years, n/a, unknown),
blinding of exposure status (yes, no, n/a, unknown),
and completeness of follow-up (percentage, n/a, un-
known).
We extracted data allowing us to calculate both
unadjusted and adjusted odds ratios to estimate the
association between cigarette smoking and the risk of
urinary tract cancer. We constructed two-way contin-
gency tables for each study, based on exposure fre-
quency distributions, to calculate the unadjusted odds
ratios. Adjusted odds ratios were extracted directly
from the original reports. Because we considered age
and gender to be the most important confounding
variables, the authors of the original articles had to
have adjusted for at least these two variables for in-
clusion in the calculation of adjusted summary esti-
mates. If studies reported gender-stratified age-ad-
justed odds ratios, we combined these estimates by
Smoking and Bladder Cancer/Zeegers et al. 631
calculating age- and gender-adjusted odds ratios,13
because from both theoretically and statistically
points of view, gender is probably a confounder in the
association between cigarette smoking and bladder
cancer. For studies that reported separate adjusted
odds ratios for several exposure strata, we combined
the exposure specific odds ratios by using the preva-
lence of the noncases as weight.14 Summary odds ra-
tios were calculated for smoking status (non-, former,
and current smoker), smoking amount (0, 1–20, and .
20 cigarettes/day), smoking duration (# 20 and . 20
years), smoking cessation (. 10 and # 10 years), and
age at first exposure of smoking (20 years and # 20
years). Unfortunately, most component studies did
not include simultaneously different smoking charac-
teristics in a regression model to estimate the impact
of cigarette smoking status, amount, duration, and age
at first exposure solely.
Statistical Analysis
To detect publication or related biases, we explored
heterogeneity in funnel plots, i.e., plots of effect esti-
mates against their estimated precision (reciprocal of
the variance).15 We examined funnel plot asymmetry
visually and measured the degree of asymmetry by
using Egger’s unweighted regression asymmetry
test.16 If a study has appeared in more than one pub-
lication, data from the last publication were used for
statistical analysis. We estimated the summary odds
ratios and corresponding 95% confidence intervals
(CIs) with random effects meta-regression analysis by
using the Stata statistical software.17 The between-
study variance was estimated iteratively, by using the
empiric Bayes method.18 We analyzed the results for
men and women both separately and combined, de-
pending on available data in the original studies. To
explore reasons for the observed heterogeneity, we
performed sensitivity analyses on study characteristics
and tested their influence on the association between
current cigarette smoking and urinary tract cancer. We
estimated the population attributable risk of urinary
tract cancer for men and women based on the pro-
portion of cigarette smokers in the European Union
and the results of the current meta-analysis.
RESULTS
Study Characteristics
We identified 59 articles reporting follow-up or case–
control studies on cigarette smoking and incident uri-
nary tract cancer published between 1968 and
199819 –77 (Table 1). Generally, the association between
cigarette smoking and urinary tract cancer was not
the main research hypothesis. Eighteen articles
were excluded from the analyses because the same
study appeared in publications that were more re-
cent. The remaining 41 articles described 8 follow-
up studies40,44,52,60,67,69,70,72 and 35 case–control stud-
ies.19–23,25,29,32,35,36,41,43,46,49,50,53–55,57–59,61,62,64–66,68,71,73–77
One case– control study that provided separate asso-
ciations for parts of the study performed in the United
States, United Kingdom, and Japan was considered as
three separate studies.29 The case–control studies were
population-based (n 5 12),23,29,43,58,6165,66,71,75,77 hospi-
tal-based (n 5 20)19–22,25,32,35,36,38,49,50,54,55,57,59,64,68,73,74,76
or neighborhood-based (n 5 1).46 Two case– control
studies used both population- and hospital-based
controls.53,62 The controls in most hospital-based
case– control studies did not have any smoking-re-
lated disease. The case– control studies also varied
with regard to their criteria of case selection. Thirteen
case– control studies identified cancer cases in de-
fined populations.23,25,36,46,55,58,62,64 – 66,71,75,77 Twenty
case– control studies selected cases from hospi-
tals,19,20–22,29,32,35,38,43,49,50,53,54,57,59,61,68,73,74,76 and two
case–control studies used both populations and hospi-
tals.19,43 Information on cigarette smoking was obtained
by interview (n 5 29),19–23,29,32,38,43,46,49,50,53–55,57–61,
64–66,68,73–75 self-administered questionnaire (n 5
12),25,35,36,40,44,52,62,69,70,72,76,77 or both techniques (n
5 1).71 One follow-up study used medical files to obtain
data on cigarette smoking.67 Some studies included all
neoplasms of the urinary tract as cases, of which greater
than 90% were found to involve bladder cancer (n
5 11).29,35,40,57,60–62,72,76 Other studies defined case sta-
tus by incident bladder cancer (n 5 29),19–21,
23,25,32,36,38,43,44,49,50,52–55,59,64–71,73–75,77 carcinomas of the
renal pelvis (n 5 1),22 or carcinomas of renal pelvis and
ureter combined (n 5 2).46,58 Most studies used histo-
logically confirmed cases with transitional cell carcino-
mas (Table 1).
Risk Estimation
We could not identify heterogeneity in funnel plots,
neither visually nor in terms of statistical significance
(P values $ 0.40 for current smoking) (Fig. 1). Tables 2
and 3 summarize the unadjusted and adjusted results
of observational studies reporting the associations for
different cigarette smoking characteristics, respec-
tively.
Current cigarette smokers have approximately
three times the risk of urinary tract cancer of non-
smokers. The adjusted summary odds ratios for cur-
rent cigarette smokers compared with nonsmokers
were 3.18 (CI, 2.35– 4.29) for studies with men, 2.90
(CI, 2.01– 4.19) for studies with women, and 3.33 (CI,
2.63– 4.21) for studies with men and women combined
(Table 3). Smoking cessation might be beneficial, al-
though former smokers still have an increased risk of
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TABLE 1
Study Characteristics of Published Epidemiologic Studies Concerning Cigarette Smoking and Cancer of the Urinary Tract,
Ordered by Year of Publication
Ref. First author Year Country Anatomic site
Study design
Cigarette smoking
assessmentCohort study
Case–control study
Case source Control source
19 Dunham 1968 U.S. Bladder — Both Hospital Interview
20 Anthony 1970 U.K. Bladder — Hospital Hospital Interview
21 Tyrrell 1971 Ireland Bladder — Hospital Hospital Interview
22 Armstrong 1976 U.K. Renal pelvis — Hospital Hospital Interview
23 Miller 1977 Canada Bladder — Population Populationa Interview
24b Wynder 1977 U.S. Bladder — Hospital Hospital Interview
25 Tola 1980 Finland Bladder — Population Hospital Questionnairec
26b Vineis 1981 Italy Bladder — Hospital Hospital Interview
27b Vineis 1983 Italy Urinary tractd — Hospital Hospital Interview
28b Vineis 1984 Italy Bladder — Hospital Hospital Interview
29 Morrison 1984 U.S./U.K./Japan Urinary tractd — Hospital Population Interview
30b Hartge 1985 U.S. Bladder — Population Population Interview
31b Marret 1985 U.S. Bladder — Population Population Interview
32 Rebekalos 1985 Greece Bladder — Hospital Hospital Interview
33b Vineis 1985 Italy Bladder — Hospital Hospital Interview
34b Wynder 1985 U.S. Bladder — Hospital Hospital Interview
35 Bravo 1986 Spain Urinary tractd — Hospital Hospital Questionnairec
36 Brownson 1987 U.S. Bladder — Population Hospital Questionnairec
37b Hartge 1987 U.S. Bladder — Population Population Interview
38b Vineis 1988 Italy Bladder — Hospital Hospital Interview
39b Slatterly 1988 U.S. Bladder — Population Population Interview
40 Steineck 1988 Sweden Urinary tractd Yes — — Questionnairec
41b Augustine 1988 U.S. Bladder — Hospital Hospital Interview
42b La Vecchia 1989 Italy Bladder — Hospital Hospital Interview
43 Burch 1989 Canada Bladder — Both Population Interview
44 Helzlsouer 1989 U.S. Bladder Yes — — Questionnairec
45b Clavel 1989 France Bladder — Hospital Hospital Interview
46 Ross 1989 U.S. Renal pelvise — Population Neighborhood Interview
47b D’Avanzo 1990 Italy Bladder — Hospital Hospital Interview
48b Hartge 1990 U.S. Bladder — Population Population Interview
49 Iyer 1990 U.S. Bladder — Hospital Hospital Interview
50b Harris 1990 U.S. Bladder — Hospital Hospital Interview
51b La Vecchia 1991 Italy Bladder — Hospital Hospital Interview
52 Mills 1991 U.S. Bladder Yes — — Questionnairec
53 Lopez-Abente 1991 Spain Bladder — Hospital Both Interview
54 De Stefani 1991 Uruguay Bladder — Hospital Hospital Interview
55 Burns 1991 U.S. Bladder — Population Hospital Interview
56b D’Avanzo 1992 Italy Bladder — Hospital Hospital Interview
57 Kunze 1992 Germany Urinary tractd — Hospital Hospital Interview
58 McLaughlin 1992 U.S. Renal pelvise — Population Population Interview
59b Cordier 1993 France Bladder — Hospital Hospital Interview
60 Chyou 1993 U.S. Urinary tractd Yes — — Interview
61 Hayes 1993 U.S. Urinary tractd — Hospital Population Interview
62 Sorahan 1994 U.K. Urinary tractd — Population Bothf Questionnairec
63b Barbone 1994 Italy Bladder — Hospital Hospital Interview
64 Vizcaino 1994 Zimbabwe Bladder — Population Hospital Interview
65 Momas 1994 France Bladder — Population Population Interview
66 Sturgeon 1994 U.S. Bladder — Population Population Interview
67 Tremblay 1995 Canada Bladder Yes — — Medical files
68 D’Avanzo 1995 Italy Bladder — Hospital Hospital Interview
69 McCarthy 1995 U.S. Bladder Yes — — Questionnairec
70 Murata 1996 Japan Bladder Yes — — Questionnairec
71 Bruemmer 1996 U.S. Bladder — Population Population Both
72 Engeland 1996 Norwegen Urinary tractd Yes — — Questionnairec
73 Bedwani 1997 Egypt Bladder — Hospital Hospital Interview
74 Donato 1997 Italy Bladder — Hospital Hospital Interview
75 Teschke 1997 Canada Bladder — Population Population Interview
76 Sorahan 1998 U.S. Urinary tractd — Hospital Hospital Questionnairec
77 Koivusalo 1998 Finland Bladder — Population Population Questionnairec
a And neighborhood.
b Study has appeared in more than one publication.
c Self-administered questionnaire.
d Includes bladder carcinoma and at least one other urinary tract cancer.
e And ureter.
f Only data from population controls were used.
urinary tract cancer compared with nonsmokers. The
adjusted summary odds ratios for former smokers
were 2.90 (CI, 1.41–5.98), 1.34 (CI, 1.03–1.74), and 1.98
(CI, 1.72–2.29) for studies with men only, women only,
or men and women combined, respectively (Table 3).
The risk of urinary tract cancer is associated with
the number of cigarettes smoked per day (Table 3).
The adjusted summary odds ratios for smoking up to
20 cigarettes per day ranged from 1.66 (CI, 0.93–2.97)
for studies with women to 2.66 (CI, 2.06 –3.42) for
FIGURE 1. Funnel plot for current cigarette
smokers compared with nonsmokers is shown.
Dashed and solid reference lines indicate no
effect and total summary odds ratio, respec-
tively.
TABLE 2
Unadjusted Summary Odds Ratios for Different Cigarette Smoking Characteristics
Determinants
Male Female Male and Female
na OR CI na OR CI na ORb CI
Smoking status
Nonsmoker 1.00 Reference 1.00 Reference 1.00 Reference
Former smoker 23 2.00 1.57–2.55 12 1.66 1.13–2.44 22 1.71 1.51–1.94
Current smoker 24 2.81 2.31–3.43 15 2.33 1.82–2.99 23 2.57 2.20–3.00
Smoking amount
Nonsmoker 1.00 Reference 1.00 Reference 1.00 Reference
1–20 cigarettes/day 11 2.34 1.77–3.09 7 1.79 1.39–2.30 14 2.17 1.75–2.70
. 20 cigarettes/day 11 2.91 2.09–4.06 5 2.57 2.24–2.94 14 2.79 2.00–3.90
Smoking duration (yrs)
# 20 1.00 Reference 1.00 Reference 1.00 Reference
. 20 10 2.59 1.83–3.67 5 2.73 1.63–4.57 5 2.13 1.70–2.67
Smoking cessation (yrs)
. 10 1.00 Reference 1.00 Reference 1.00 Reference
# 10 6 1.23 0.80–1.87 2 0.38 0.17–0.85 4 1.36 0.76–2.43
Age at first exposure (yrs)
. 20 1.00 Reference 1.00 Reference 1.00 Reference
# 20 13 1.25 1.07–1.47 3 1.70 1.09–2.65 5 1.26 1.12–1.42
OR: odds ratio; CI: 95% confidence interval.
a No. of analyzed studies.
b Calculated from collapsed contingency tables.
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studies with men. Men or women who smoked more
than 20 cigarettes per day appeared to have higher
risks. The adjusted summary odds ratios were: 3.51
(CI, 2.73– 4.52), 2.48 (CI, 1.34 – 4.61), and 3.15 (CI, 2.62–
3.79) for studies with men only, women only, or men
and women combined, respectively (Table 3).
For both smoking status and smoking amount, the
unadjusted estimation for the summary odds ratios
were usually lower than the age- and gender-adjusted
estimates, although the unadjusted estimates were
based on a larger set of studies (Table 2). For smoking
duration, smoking cessation, and age at first exposure
of smoking, only unadjusted summary odds ratios
could be calculated.
The risk of urinary tract cancer increased with
increasing duration of cigarette smoking (Table 2).
Subjects who smoked for greater than 20 years ap-
peared to develop urinary tract cancer at 2–3 times the
rate in subjects who smoked cigarettes for less than 20
years. The corresponding summary odds ratios were
2.59 (CI, 1.83–3.67) for studies with men, 2.73 (CI,
1.63– 4.57) for studies with women, and 2.13 (CI, 1.70 –
2.67) for studies in which the data for men and women
were collapsed (Table 2).
The time since smoking cessation among former
smokers also appeared to be an important smoking
characteristic (Table 2). Men who stopped smoking for
less than 10 years had higher risks of urinary tract
cancer compared with men who stopped smoking for
longer than 10 years (summary odds ratio, 1.23; CI,
0.80 –1.87). However, the reduction in risk for women
appeared to be greatest in the first decade after quit-
ting, although this is only based on two case– control
studies (summary odds ratio, 0.38; CI, 0.17– 0.85).43,57
The summary odds ratio for studies with collapsed
data on men and women was 1.36 (CI, 0.76 –2.43)
(Table 2).
Furthermore, persons who started smoking at
younger ages (younger than 20 years) tended to have
higher risks of urinary tract cancer compared with
persons who start smoking at older ages (Table 2). The
corresponding summary odds ratios were 1.25 (CI,
1.07–1.47) for studies with men, 1.70 (CI, 1.09 –2.65) for
studies with women, and 1.26 (CI, 1.12–1.42) for stud-
ies with men and women combined (Table 2).
Sensitivity Analysis
We further examined the crude association of current
smoking by geographic area, year of publication, study
design, measuring instrument, sources of cases and
controls, and anatomic site of the tumor to explore
their influence on the outcome estimates in studies
that provided information for men and women com-
bined (Fig. 2). No tests for interaction were statistically
significant. Most subset specific summary odds ratios
did not differ substantially, although it appeared that
the odds ratios from studies published before 1980
were lower than from more recent studies. Further-
more, the summary associations for case– control
studies were higher than for follow-up studies. Selec-
tion on anatomic site of the tumor did not alter the
summary odds ratios (Fig. 2).
Population Attributable Risk
In the European Union, 28% of women and 43% of
men smoke cigarettes.78 Based on these figures and
the age-adjusted results of the current meta-analysis,
our estimates show that cigarette smoking might ac-
count for 34.7% of all female urinary tract cancer,
TABLE 3
Adjusted Summary Odds Ratios for Different Cigarette Smoking Characteristics
Determinants
Male Female Male and Female
na ORb CI na ORb CI na ORc CI
Smoking status
Nonsmoker 1.00 Reference 1.00 Reference 1.00 Reference
Former smoker 14 2.90 1.41–5.98 6 1.34 1.03–1.74 13 1.98 1.72–2.29
Current smoker 13 3.18 2.35–4.29 7 2.90 2.01–4.19 13 3.33 2.63–4.21
Smoking amount
Nonsmoker 1.00 Reference 1.00 Reference 1.00 Reference
, 20 cigarettes/day 9 2.66 2.06–3.42 4 1.66 0.93–2.97 6 2.04 1.82–2.30
# 20 cigarettes/day 9 3.51 2.73–4.52 4 2.48 1.34–4.61 6 3.15 2.62–3.79
OR: odds ratio; CI: 95% confidence interval.
a No. of analyzed studies.
b Adjusted for age and gender.
c Adjusted for age.
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whereas in men 50.0% of incidences of the disease
may be associated with cigarette smoking.
DISCUSSION
The possible association between cigarette smoking
and cancer of the urinary tract has been extensively
investigated in 43 epidemiologic studies. These pri-
mary studies can be considered as the best available
evidence. The summarized findings suggest a substan-
tial increase of risk of urinary tract cancer for cigarette
smokers. Smoking amount and smoking duration
were positively associated with urinary tract cancer
risk. For age at first exposure and smoking cessation, a
negative association was found.
Unfortunately, the included studies did not pro-
vide sufficient information to estimate adjusted sum-
mary odds ratios for all smoking characteristics. For
smoking duration, smoking cessation, and age at first
exposure of smoking only unadjusted summary odds
ratios could be calculated. The summary odds ratios
for smoking status and smoking amount increased
after adjustment for age and gender. Therefore, we
expect the crude estimates for smoking duration,
smoking cessation, and age at first exposure to be
underestimated.
We did not attempt to uncover unpublished ob-
servations and excluded studies that did not meet the
predetermined criteria. Publication bias might arise
by excluding these studies. However, we could not
identify funnel plot heterogeneity in our meta-analy-
sis, either visually or in terms of statistical significance.
Because of potential heterogeneity in populations,
designs, and analyses of various studies, we assumed
that the true effects being estimated would vary be-
tween the studies in addition to the usual sampling
variation in the estimates (within studies). To account
for both sources of variation, we used random effects
meta-regression analysis to combine the results from
the primary studies.18 The random effect approach
provides some allowance for heterogeneity in studies
beyond sampling error.
The epidemiology of urinary tract cancer is rather
complex. For example: substantial differences exist in
urinary tract cancer rates between white and black
people; urinary tract cancer is considerably more
common in men than in women; and the incidence of
this cancer varies between North America and Eu-
rope.79 The race of the study population in almost all
component studies was white. Therefore, the influ-
ence of race on the association between cigarette
smoking and urinary tract cancer could not be inves-
tigated in the current meta-analysis. For both men
and women, we found similarly increased urinary
tract cancer risks for cigarette smoking. Furthermore,
the summary odds ratios were similar for different
geographic areas.
Results from sensitivity analyses suggested that
the summary odds ratios were comparable for differ-
FIGURE 2. Forest plot is shown of crude
summary odds ratios and 95% confidence in-
tervals of urinary tract cancer for current cig-
arette smokers compared with nonsmokers, by
study design, measuring instrument, source of
cases and controls, and tumor site for case–
control studies with men and women com-
bined. Dashed and solid vertical reference
lines indicate no effect and total summary odds
ratio, respectively.
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ent types of exposure measurement, for different tu-
mor sites, and for different sources of the cases and
controls in the case– control studies. The summary
estimates were also similar between the different years
of publication, although studies published before 1980
yielded to a lower summary odds ratio than studies
published after 1980. This difference could not be
explained by diversity in population or methodology
between studies published before and after 1980 and
is probably an artifact of chance. It appeared that the
summary estimates of case– control studies were
somewhat higher than for follow-up studies. This con-
trast, although not statistically significant, might be a
consequence of differential recall bias in case– control
studies because patients with bladder cancer are pos-
sibly more sensitized toward recalling smoking habits
than noncases.
The precise mechanism by which cigarette smok-
ing causes urinary tract cancer has yet to be deter-
mined. The finding that both age at first exposure and
cessation of exposure have an influence in modifying
the summary odds ratio of urinary tract cancer might
suggest that two stages in the mechanism of urinary
tract carcinogenicity are involved, one early and one
late.80 However, few studies simultaneously included
different smoking characteristics in a regression
model to estimate the independent contribution of
these smoking characteristics. It seems most likely
that the risk of urinary tract cancer is related to some
of the large number of chemicals present in smoke.
2-Naphthylamine and 4-aminobiphenyl are the lead-
ing candidates as the specific etiologic agents.3,8,9,81,82
Several nitrosamines have been shown to produce
bladder cancer in animal models.9 Tars might induce
bladder papillomas and carcinomas in mice.8 To our
knowledge, no epidemiologic study on the association
between tars and nicotine exposure and bladder can-
cer risk has been conducted, although one case– con-
trol study reported a diminution of risk from the
smoking of light tobacco.53 Molecular studies have
suggested that exposure to certain carcinogens in cig-
arette smoke may contribute to DNA damage, i.e.,
chromosome 9 defects83 and TP53 mutations.84 These
alterations are the most frequently known molecular
abnormalities in the etiology of bladder cancer.83 Fur-
thermore, genetic polymorphisms, e.g., of the
arylamine N-acetyltransferase or glutathione S-trans-
ferase Mu1 (GSTM1), may alter metabolism of tobacco
carcinogens. Slow acetylation or lack of GSTM1 activ-
ity (which is present in 50% of whites) might result in
a higher concentration of tobacco carcinogens in the
bladder and consequently enhance the risk of bladder
cancer among cigarette smokers.85–7 Unfortunately,
the data of the current meta-analysis could not be
stratified upon these or other polymorphisms. Besides
the effect that many compounds in cigarettes can
cause genotoxic events in the urothelium, cigarette
smoking have been found to increase proliferation, as
evidenced by hyperplasia of the urinary tract epithe-
lium.9
In accordance with earlier reviews, it can be con-
cluded that cigarette smoking is an important cause of
urinary tract cancer for both men and women. Current
cigarette smokers have an approximately threefold
higher risk of urinary tract cancer than nonsmokers.
This risk increases with the number of cigarettes
smoked per day and the number of years smoked.
Both age at first exposure and cessation of cigarette
smoking have an influence on modifying the risk of
urinary tract cancer. Approximately half of male uri-
nary tract cancer and one-third of female urinary tract
cancer might be attributable to cigarette smoking.
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